James Codella1, Nasia Safdar2, Rick Heffernan3, Oguzhan Alagoz1. 1. Department of Industrial & Systems Engineering, University of Wisconsin-Madison, Madison, WI (JC, OA) 2. Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI and William S. Middleton Memorial Veterans Hospital, Madison, WI (NS). 3. Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health, Madison, WI (RH)
Abstract
BACKGROUND: Control of Clostridium difficile infection (CDI) is an increasingly difficult problem for health care institutions. There are commonly recommended strategies to combat CDI transmission, such as oral vancomycin for CDI treatment, increased hand hygiene with soap and water for health care workers, daily environmental disinfection of infected patient rooms, and contact isolation of diseased patients. However, the efficacy of these strategies, particularly for endemic CDI, has not been well studied. The objective of this research is to develop a valid, agent-based simulation model (ABM) to study C. difficile transmission and control in a midsized hospital. METHODS: We develop an ABM of a midsized hospital with agents such as patients, health care workers, and visitors. We model the natural progression of CDI in a patient using a Markov chain and the transmission of CDI through agent and environmental interactions. We derive input parameters from aggregate patient data from the 2007-2010 Wisconsin Hospital Association and published medical literature. We define a calibration process, which we use to estimate transition probabilities of the Markov model by comparing simulation results to benchmark values found in published literature. RESULTS: In a comparison of CDI control strategies implemented individually, routine bleach disinfection of CDI-positive patient rooms provides the largest reduction in nosocomial asymptomatic colonization (21.8%) and nosocomial CDIs (42.8%). Additionally, vancomycin treatment provides the largest reduction in relapse CDIs (41.9%), CDI-related mortalities (68.5%), and total patient length of stay (21.6%). CONCLUSION: We develop a generalized ABM for CDI control that can be customized and further expanded to specific institutions and/or scenarios. Additionally, we estimate transition probabilities for a Markov model of natural CDI progression in a patient through calibration.
BACKGROUND: Control of Clostridium difficileinfection (CDI) is an increasingly difficult problem for health care institutions. There are commonly recommended strategies to combat CDI transmission, such as oral vancomycin for CDI treatment, increased hand hygiene with soap and water for health care workers, daily environmental disinfection of infected patient rooms, and contact isolation of diseased patients. However, the efficacy of these strategies, particularly for endemic CDI, has not been well studied. The objective of this research is to develop a valid, agent-based simulation model (ABM) to study C. difficile transmission and control in a midsized hospital. METHODS: We develop an ABM of a midsized hospital with agents such as patients, health care workers, and visitors. We model the natural progression of CDI in a patient using a Markov chain and the transmission of CDI through agent and environmental interactions. We derive input parameters from aggregate patient data from the 2007-2010 Wisconsin Hospital Association and published medical literature. We define a calibration process, which we use to estimate transition probabilities of the Markov model by comparing simulation results to benchmark values found in published literature. RESULTS: In a comparison of CDI control strategies implemented individually, routine bleach disinfection of CDI-positive patient rooms provides the largest reduction in nosocomial asymptomatic colonization (21.8%) and nosocomial CDIs (42.8%). Additionally, vancomycin treatment provides the largest reduction in relapse CDIs (41.9%), CDI-related mortalities (68.5%), and total patient length of stay (21.6%). CONCLUSION: We develop a generalized ABM for CDI control that can be customized and further expanded to specific institutions and/or scenarios. Additionally, we estimate transition probabilities for a Markov model of natural CDI progression in a patient through calibration.
Authors: Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun Journal: Am J Gastroenterol Date: 2013-02-26 Impact factor: 10.864
Authors: C Landelle; M Verachten; P Legrand; E Girou; F Barbut; C Brun-Buisson; C Brun Buisson Journal: Infect Control Hosp Epidemiol Date: 2013-11-26 Impact factor: 3.254
Authors: Susan E Sharp; Lila O Ruden; Julie C Pohl; Patricia A Hatcher; Linda M Jayne; W Michael Ivie Journal: J Clin Microbiol Date: 2010-04-07 Impact factor: 5.948
Authors: Markus Dettenkofer; Sibylle Wenzler; Susanne Amthor; Gerd Antes; Edith Motschall; Franz D Daschner Journal: Am J Infect Control Date: 2004-04 Impact factor: 2.918
Authors: Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser Journal: Emerg Infect Dis Date: 2008-07 Impact factor: 6.883
Authors: Anna K Barker; Elizabeth Scaria; Oguzhan Alagoz; Ajay K Sethi; Nasia Safdar Journal: Infect Control Hosp Epidemiol Date: 2020-02-13 Impact factor: 3.254
Authors: Luis Furuya-Kanamori; Samantha J McKenzie; Laith Yakob; Justin Clark; David L Paterson; Thomas V Riley; Archie C Clements Journal: PLoS One Date: 2015-03-16 Impact factor: 3.240
Authors: Natalia Blanco; Betsy Foxman; Anurag N Malani; Min Zhang; Seth Walk; Alexander H Rickard; Marisa C Eisenberg Journal: PLoS One Date: 2017-08-11 Impact factor: 3.240
Authors: Laith Yakob; Thomas V Riley; David L Paterson; John Marquess; Ricardo J Soares Magalhaes; Luis Furuya-Kanamori; Archie C A Clements Journal: Sci Rep Date: 2015-07-28 Impact factor: 4.379